Assessment of Alcon's Ocular Image Quantification System

• Status: Completed
• Trial end date: 2011-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to evaluate ocular responses with different allergen provocation methods.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Dextrans; Olopatadine Hydrochloride; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• History of allergic conjunctivitis;

• Active signs and symptoms of ocular allergies;

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• History of dry eye;

• Presence of ocular infection;

• Presence of severe or serious ocular conditions;

• Symptoms of allergic conjunctivitis;

• Use of topical or systemic ocular medications as specified in protocol;

• Ocular surgery or laser surgery within 6 months of study start;

• Unwilling to discontinue contact lens wear 72 hours prior to Visit 1 and during study period;

• Other protocol-defined exclusion criteria may apply.